Revance Shares Jump 18% After FDA Approves Botox Rival Daxxify

Revance Therapeutics says its new treatment, Daxxify, diminishes facial wrinkles for up to six months.
http://dlvr.it/SY2xvJ

Comments

Popular posts from this blog